Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 20 Prostatic Neoplasms 11 Neoplasm Metastasis 9 Melanoma 8 Lung Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Hepatocellular 8 Kidney Neoplasms 7 Sarcoma 6 Liver Neoplasms 6 Triple Negative Breast Neoplasms 3 Thyroid Neoplasms 3 Small Cell Lung Carcinoma 3 Osteosarcoma 3 Desmoid Tumors 3 Carcinoma, Ductal, Breast 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Pain 2 Keratosis, Actinic 2 Esophageal Neoplasms 2 Disease 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Wilms Tumor 1 Uveal Melanoma 1

Interventions

Oxaliplatin 32 Fluorouracil 24 Gemcitabine 23 Leucovorin 19 Docetaxel 19 pembrolizumab 17 Capecitabine 15 Radiotherapy 14 Irinotecan 13 Cisplatin 11 Bevacizumab 11 Nivolumab 8 130-nm albumin-bound paclitaxel 8 Trastuzumab 7 Erlotinib Hydrochloride 7 Cyclophosphamide 7 Albumin-Bound Paclitaxel 7 Radiosurgery 6 Paclitaxel 6 Taxes 5 S 1 (combination) 5 Metformin 5 Carboplatin 5 Blood Specimen Collection 5 Sunitinib 4 Sorafenib 4 Pemetrexed 4 Esophagectomy 4 Chemoradiotherapy 4 Cetuximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenocarcinoma × Cryosurgery × Clear all

NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡